Navigation Links
Sinovac Announces that Government Investigation Rules Out Healive's Role in Child's Death
Date:12/31/2008

BEIJING, Dec. 31 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Alternext US: SVA), a leading provider of vaccines in China, today provided an update regarding the suspension of the Company's inactivated hepatitis A vaccine Healive(R), following a report of the death of a minor in the Fengtai District in the City of Beijing on November 27, 2008. The Company learnt from authorities that according to the autopsy results, the death was caused by myocarditis, an inflammation of the muscular part of the heart generally due to a viral or bacterial infection. It may cause chest pain, rapid signs of heart failure, or sudden death. The administration of Healive was not a factor.

Mr. Xiaofeng Liang, director of National Planed Immunization Center of China CDC, stated, "All vaccines available on the Chinese market are considered safe products as they are produced and inspected through strict processes. It is impossible to cause disease by vaccinating with inactivated vaccines."

Mr. Weidong Yin, Chairman, President and CEO of Sinovac Biotech Ltd., commented, "Although the autopsy results showed that the death of the minor was not related to the administration of our vaccine, we are sorry for the family's loss. We are confident about the safety profile of Healive as supported by the clinical trials and the track record of vaccine administration following launch in 2002. Since vaccination has proven to be the most effective and successful approach to preventing diseases, we continue to supply our high quality vaccines in order to improve public health and maximize shareholder value."

As previously disclosed, the Health Services Bureau of Fengtai District in the City of Beijing suspended the use of 83 doses of inactivated hepatitis A vaccine Healive(R) following a report of the death of a minor in the Fengtai District on November 27, 2008, which coincided with the administration of the vaccine two
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Sinovac Provides Support to Chinas Ministry of Health to Aid Earthquake Victims
2. Sinovac to Present at the Brean Murray, Carret & Co. Fourth Investor Tour of China
3. PersonalDiets Announces New Plan-A-Meal Tools to Help With New Years Weight Loss Resolutions!
4. Labopharm Announces FDA Approval of Once-Daily RYZOLT(TM) (Tramadol HCL Extended Release Tablets) for Management of Moderate to Moderately Severe Chronic Pain
5. China Medical Technologies Announces the Completion of the Sale of its HIFU Business
6. American Scientific Resources Announces Addition of New Board Members
7. Blue Cross and Blue Shield of Oklahoma Announces Autism Benefits
8. Versus Technology Announces Fiscal Year Results
9. Perrigo Announces FDA Final Approval for Ibuprofen PM
10. Ocean Spray(R) Announces Sugar-Free Drink Mixes - A Sweet Way for Dieters to Stick to Their Resolutions
11. Prime Companies Announces Launch of New Dental Web Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... November 22, 2014 Setria® Glutathione ... (TGA) approved it for use “as a therapeutically ... listed within the Therapeutic Goods (Listing) Notice 2014 ... Kyowa Hakko’s Setria® Glutathione will be exclusivity distributed ... that sources and imports fine chemicals to Australian ...
(Date:11/22/2014)... 22, 2014 In order to provide better ... of cocktail party dresses. The business knows that a suitable ... occasions. , Now, the party dresses supplier’s high ... off. As the leading company in fashion industry, LunaDress understands ... for every customer. So it always raises the professional level ...
(Date:11/22/2014)... November 22, 2014 A petition seeking ... http://www.morcellatorlawsuit2015.com ) in minimally-invasive hysterectomies and fibroid removal ... the end of October, Bernstein Liebhard LLP reports. ... as of November 21st, 2014. That represents an increase ... had signed on to the campaign.* , The campaign ...
(Date:11/22/2014)... November 22, 2014 The topic of ... of block retaining walls. The article states that, “While they ... several necessary steps that go into creating this powerful look.” ... a retaining wall is choosing which kind of block matches ... , B&D Rockeries says, “The two main options are concrete ...
(Date:11/22/2014)... Hastings and Hastings, a discount accident ... providing clients with the option of leaving an online ... flexible, intuitive and easy to navigate website that has ... Google + allows clients to research the Hastings and ... informed decision when retaining an attorney. Those who have ...
Breaking Medicine News(10 mins):Health News:Setria® Glutathione Now Available in Australia 2Health News:Setria® Glutathione Now Available in Australia 3Health News:LunaDress Unveils Fabulous Cocktail Party Dresses 2Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 4Health News:5 Step Installment of Block Retaining Walls is Topic of Latest Article by B&D Rockeries 2Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 2Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 3
... often may have more to do with patients who ... medication, according to researchers in Northern Ireland. ... poorly adherent to inhaled and oral corticosteroid therapy," wrote ... The results of the study were published ...
... Alberta medical researcher being hailed as a world leader in ... pioneering work in the development of a new class of ... The Canadian Cardiovascular Society is giving its 2009 Young ... Y. Oudit (pronounced OO-diht), an assistant professor in the Faculty ...
... Shire plc (LSE: SHP, NASDAQ: SHPGY), the global ... pharmacokinetics of its Attention-Deficit/Hyperactivity Disorder (ADHD) medication, Vyvanse ... provided similar concentrations of its active medication in ... administered orally. Specifically, the overall rate and ...
... since vaccine was introduced in 2006 , THURSDAY, Oct. 22 ... started in the United States in 2006, there,s been a ... in children, a new government study shows. , Rotavirus is ... younger than 5. Before 2006, rotavirus caused 20 to 60 ...
... all Americans who want shot will be able to get ... reports of swine flu infections continue to pour in from ... why delivery of stocks of the long-awaited H1N1 vaccine are ... million doses would be on hand by Oct. 15, but ...
... ever are using cell phones and computers, a technology ... into second-class citizens, according to Florida State University researchers. ... Psychology, and Walter R. Boot, an assistant professor of ... older adults pose barriers to adopting new forms of ...
Cached Medicine News:Health News:'Difficult-to-treat asthma' may be due to difficult-to-treat patients 2Health News:'Difficult-to-treat asthma' may be due to difficult-to-treat patients 3Health News:Canadian Cardiovascular Society recognizes trailblazing work by U of Alberta heart researcher 2Health News:Canadian Cardiovascular Society recognizes trailblazing work by U of Alberta heart researcher 3Health News:Vyvanse Capsules CII administration through 2 routes demonstrated similar pharmacokinetic profile 2Health News:Vyvanse Capsules CII administration through 2 routes demonstrated similar pharmacokinetic profile 3Health News:Rotavirus Vaccine Cutting Infection Rates Among Kids 2Health News:Production Problems Plague Delivery of Swine Flu Vaccine 2Health News:Production Problems Plague Delivery of Swine Flu Vaccine 3Health News:Production Problems Plague Delivery of Swine Flu Vaccine 4Health News:No elder left behind: Researchers say designers can help close tech gap 2Health News:No elder left behind: Researchers say designers can help close tech gap 3
(Date:11/21/2014)... Nov. 20, 2014  The acceptance of two ... AAGL Global Congress demonstrates continued interest in the ... provide bowel control. One of the abstracts, presented by ... Division Chief of Urogynecology and Reconstructive Pelvic Surgery ... Award for Best Written Abstract on Urogynecology/Pelvic Floor ...
(Date:11/21/2014)... -- Oxis International, Inc. (OXIS) (OXI.PA) announced today the resignation ... J. Cataldo as Chief Executive Officer, and Steven ... Ken Eaton resigned his positions as Chief Executive ... International, Inc. to pursue new opportunities. Mr. ... of Oxis International, Inc. Mr. Cataldo will continue to serve ...
(Date:11/18/2014)... 18, 2014  NxStage ® Medical Inc. ... of innovative dialysis products , today announced ... dialyzer for the in-center, hemodialysis market.  Streamline Express ... designed to reduce the amount of labor required ... of touch point contamination sites.  The dialyzer enables ...
Breaking Medicine Technology:LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 3OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set 2
... with its Investor Day being held tomorrow in New York ... forward-looking earnings expectations for the fourth quarter of Fiscal Year ... for Fiscal Year 2013.  The Company reconfirmed ... and for all of Fiscal Year 2012, as issued in ...
... hospitals handed a resolute vote of confidence over ... enterprise clinical and financial system. Healthmark Regional Medical ... Kit Carson Memorial Hospital plan on leveraging the ... meeting the meaningful use requirements associated with the ...
Cached Medicine Technology:PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day 2PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day 3PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day 4Hospitals Across the Country Select Prognosis HIS Enterprise Clinical and Financial System 2Hospitals Across the Country Select Prognosis HIS Enterprise Clinical and Financial System 3
... The Arx Ceramic ... innovative, biocompatible implants based ... technology that offers physicians ... to other synthetic and ...
CVC 9005 Hematocrit Calibration Verification Controls are materials used for verifying the calibration and linearity of hematocrit sensors in IRMA TRUpoint cartridges for systems using software versi...
... control material used for monitoring the performance of ... for specific use on Bayer analyzers that measure ... 270) and the AVOX Systems CO-Oximeters (4000 and ... the IRMA TRUpoint®. CC 527 is available in ...
RNA1c Control is an assayed quality control material used for monitoring the performance of Bayer DCA Analyzers that measure Hemoglobin A1c. It may be used on DCA 2000 and 2000+ analyzers....
Medicine Products: